Rosetta Genomics Launches Two Assays for Bladder Cancer By: Benzinga via Benzinga May 14, 2015 at 08:50 AM EDT Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular and other diagnostics, announces that ... Read More >>